Fierce Pharma

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty Makary’s resignation,

Makary to leave role as head of FDA

The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of President Donald Trump.

FDA shake-up: Makary loyalists in limbo

FDA staffers are buzzing about who in former FDA Commissioner Marty Makary’s orbit will be next to leave the agency.
STAT

Makary’s departure and Cassidy’s tenuous Senate seat

This week's episode of “The Readout LOUD” is all about health politics, including Marty Makary's departure as FDA commissioner. Listen now.
Applied Clinical Trials Online

ACT Brief: Makary's Turbulent FDA Tenure, Pediatric Trial Experience Design, and Weight Loss Maintenance Data

In today's ACT Brief, we examine leadership instability and regulatory uncertainty during Makary's FDA tenure, how lived experience shapes pediatric trial design and performance, and Eli Lilly's weight loss maintenance data for obesity therapies.

Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

By Christy Santhosh May 13 (Reuters) - U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure comes as a positive move after a period of turmoil in the biotech sector, but until a permanent replacement is found,

Makary ouster spurs GOP friction

The resignation of President Donald Trump’s Food and Drug Administration commissioner Tuesday ruffled some feathers in Washington.
Axios on MSN

Makary's exit creates new uncertainty at FDA

Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy. But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure.